251 related articles for article (PubMed ID: 20618946)
21. NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells.
Nagel S; Venturini L; Przybylski GK; Grabarczyk P; Meyer C; Kaufmann M; Battmer K; Schmidt CA; Drexler HG; Scherr M; Macleod RA
BMC Cancer; 2009 Oct; 9():371. PubMed ID: 19835636
[TBL] [Abstract][Full Text] [Related]
22. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
23. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
[TBL] [Abstract][Full Text] [Related]
24. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
[TBL] [Abstract][Full Text] [Related]
25. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract][Full Text] [Related]
26. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].
Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291
[No Abstract] [Full Text] [Related]
27. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
28. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs.
Bergeron J; Clappier E; Radford I; Buzyn A; Millien C; Soler G; Ballerini P; Thomas X; Soulier J; Dombret H; Macintyre EA; Asnafi V
Blood; 2007 Oct; 110(7):2324-30. PubMed ID: 17609427
[TBL] [Abstract][Full Text] [Related]
30. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
[TBL] [Abstract][Full Text] [Related]
31. NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.
Nagel S; Pommerenke C; Scherr M; Meyer C; Kaufmann M; Battmer K; MacLeod RA; Drexler HG
PLoS One; 2017; 12(2):e0171164. PubMed ID: 28151996
[TBL] [Abstract][Full Text] [Related]
32. A promoter with bidirectional activity is located between TLX1/HOX11 and a divergently transcribed novel human gene.
Greene WK; Sontani Y; Sharp MA; Dunn DS; Kees UR; Bellgard MI
Gene; 2007 Apr; 391(1-2):223-32. PubMed ID: 17303350
[TBL] [Abstract][Full Text] [Related]
33. TLX1/HOX11-induced hematopoietic differentiation blockade.
Riz I; Akimov SS; Eaker SS; Baxter KK; Lee HJ; Mariño-Ramírez L; Landsman D; Hawley TS; Hawley RG
Oncogene; 2007 Jun; 26(28):4115-23. PubMed ID: 17213805
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
[TBL] [Abstract][Full Text] [Related]
35. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
Choi SH; Severson E; Pear WS; Liu XS; Aster JC; Blacklow SC
PLoS One; 2017; 12(10):e0185762. PubMed ID: 29023469
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
37. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
Sanchez-Martin M; Ferrando A
Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
[TBL] [Abstract][Full Text] [Related]
38. The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.
Zweier-Renn LA; Riz I; Hawley TS; Hawley RG
J Bone Marrow Res; 2013 Feb; 1():. PubMed ID: 25309961
[TBL] [Abstract][Full Text] [Related]
39. The nuclear oncoprotein TLX1/HOX11 associates with pericentromeric satellite 2 DNA in leukemic T-cells.
Heidari M; Rice KL; Phillips JK; Kees UR; Greene WK
Leukemia; 2006 Feb; 20(2):304-12. PubMed ID: 16357834
[TBL] [Abstract][Full Text] [Related]
40. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.
Paryan M; Mohammadi-Yeganeh S; Samiee SM; Soleimani M; Arefian E; Azadmanesh K; Poopak B; Mostafavi E; Karimipoor M; Mahdian R
Mol Biol Rep; 2013 Oct; 40(10):5531-40. PubMed ID: 23982259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
